Latest Breaking News On - Arrowhead pharmaceuticals inc - Page 4 : comparemela.com

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Releases Quarterly Earnings Results, Misses Expectations By $0 96 EPS

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Releases Quarterly Earnings Results, Misses Expectations By $0 96 EPS
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesHongbo luArrowhead pharmaceuticals price performanceArrowhead pharmaceuticalsSecurities exchange commissionMorgan stanleyArrowhead pharmaceuticals company profileEarnings history for arrowhead pharmaceuticalsRoyal bankNews ratings for arrowhead pharmaceuticals dailyArrowhead pharmaceuticals incGet free reportExchange commissionDirector victoria vakienerArrowhead pharmaceuticals daily

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Trading Down 6 5% After Earnings Miss

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Trading Down 6 5% After Earnings Miss
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesHongbo luKenneth allen myszkowskiNews ratings for arrowhead pharmaceuticals dailyArrowhead pharmaceuticals company profileCapital international investorsArrowhead pharmaceuticals incSecurities exchange commissionRoyal bankGoldman sachs group incArrowhead pharmaceuticals trading downArrowhead pharmaceuticalsMorgan stanleyNorges bankAvoro capital advisorsGet free report

Arrowhead Pharmaceuticals (ARWR) Buy Rating Reaffirmed at Chardan Capital

Arrowhead Pharmaceuticals (ARWR) Buy Rating Reaffirmed at Chardan Capital
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesHongbo luArrowhead pharmaceuticals price performanceWashington trust advisors incArrowhead pharmaceuticals company profileArrowhead pharmaceuticalsArrowhead pharmaceuticals incQuest partnersThird bancorpFifth third bancorpAnalyst recommendations for arrowhead pharmaceuticalsMorgan stanleyRoyal bankNews ratings for arrowhead pharmaceuticals dailyInstitutional investors weigh in on arrowhead pharmaceuticalsSecurities exchange commission

Arrowhead Pharmaceuticals, Inc (NASDAQ:ARWR) Q2 2024 Earnings Call Transcript

Arrowhead Pharmaceuticals, Inc (NASDAQ:ARWR) Q2 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesEli lillyKen myszkowskiEllie merleEdward tenthoffMayank mamtaniCardiometabolic webinarJames hamiltonMaury raycroftJason gerberryChris anzaloneVince anzalonePiper sandlerArrowhead pharmaceuticals conference callAmerican thoracic societyInternational conference on antiviral research

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Receives Buy Rating from Chardan Capital

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Receives Buy Rating from Chardan Capital
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesHongbo luWashington trust advisors incAssociates corpArrowhead pharmaceuticalsArrowhead pharmaceuticals incFifth third bancorpThird bancorpArrowhead pharmaceuticals stock performanceAsset management coMitsubishi ufjRoyal bankMorgan stanleyAnalyst recommendations for arrowhead pharmaceuticalsYork state common retirement fund